Advertisement
Screener

CELCUITY INC. (CELC) Graph

CELC Revenue Flow

A current filed revenue breakdown could not be established from the retained filing evidence.

  • 2026-06-30: Research and development $31.08M; Selling, general and administrative $35.04M; Operating expenses $66.12M; Income tax (m).
  • 2026-03-31: Research and development $33.06M; Selling, general and administrative $17.44M; Operating expenses $50.51M; Income tax (m).
  • 2025-12-31: Research and development $37.63M*; Selling, general and administrative (m); Operating expenses $49.20M*; Income tax (m).
  • 2025-09-30: Research and development $34.91M; Selling, general and administrative (m); Operating expenses $42.85M; Income tax (m).

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$31.08M$35.04M$66.12M(m)-$78.86M
2026-03-31$33.06M$17.44M$50.51M(m)-$52.84M
2025-12-31$37.63M*(m)$49.20M*(m)-$50.97M*
2025-09-30$34.91M(m)$42.85M(m)-$43.80M
2025-06-30$36.41M$7.59M$44.01M(m)-$45.27M
2025-03-31$29.76M$6.37M$36.13M(m)-$37.00M
2024-09-30$27.59M(m)$30.06M(m)-$29.79M
2024-06-30$22.50M(m)$24.28M(m)-$23.72M
2024-03-31$20.65M(m)$22.49M(m)-$21.61M
2023-09-30$17.49M(m)$18.90M(m)-$18.40M
2023-06-30$13.75M(m)$15.06M(m)-$14.59M
2023-03-31$11.28M(m)$12.55M(m)-$11.94M
2022-09-30$9.62M(m)$10.64M(m)-$10.89M
2022-06-30$8.37M(m)$9.60M(m)-$9.96M
2022-03-31$6.70M(m)$7.51M(m)-$7.93M
2021-09-30$4.96M(m)$5.60M(m)-$6.03M
2021-06-30$13.07M(m)$13.64M$0.00-$14.03M
2021-03-31$2.24M(m)$2.79M$0.00-$2.79M
2020-12-31(m)(m)(m)$0.00*(m)
2020-09-30$1.96M(m)$2.48M$0.00-$2.47M
2020-06-30$1.77M(m)$2.21M$0.00-$2.20M
2020-03-31$1.85M(m)$2.31M$0.00-$2.25M
2019-09-30$1.71M(m)$2.09M$0.00-$1.98M
2019-06-30$1.47M(m)$1.84M$0.00-$1.72M
2019-03-31$1.59M(m)$1.97M$0.00-$1.85M
2018-09-30$1.60M(m)$1.98M$0.00-$1.87M
2018-06-30$1.55M(m)$1.93M$0.00-$1.82M
2018-03-31$1.55M(m)$2.08M$0.00-$1.97M
2017-09-30$1.36M(m)$1.53M$0.00-$1.76M
2017-06-30$1.30M(m)$1.61M$0.00-$1.78M
2017-03-31$908.77K(m)$993.91K$0.00-$987.35K
2016-09-30$812.80K(m)$877.54K$0.00-$868.52K

Revenue and expense 6 month

Period endResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$64.14M$52.48M$116.63M(m)-$131.71M
2025-06-30$66.17M$13.97M$80.14M(m)-$82.27M
2024-06-30$43.15M(m)$46.78M(m)-$45.33M
2023-06-30$25.02M(m)$27.60M(m)-$26.53M
2022-06-30$15.06M(m)$17.11M(m)-$17.89M
2021-06-30$15.31M(m)$16.44M$0.00-$16.82M
2020-06-30$3.61M(m)$4.52M$0.00-$4.45M
2019-06-30$3.06M(m)$3.82M$0.00-$3.57M
2018-06-30$3.09M(m)$4.01M$0.00-$3.78M
2017-06-30$2.21M(m)$2.60M$0.00-$2.76M

Revenue and expense 9 month

Period endResearch and developmentOperating expensesIncome taxNet income
2025-09-30$107.36M$122.99M(m)-$126.07M
2024-09-30$70.73M$76.84M(m)-$75.13M
2023-09-30$42.51M$46.50M(m)-$44.93M
2022-09-30$24.69M$27.75M(m)-$28.79M
2021-09-30$20.27M$22.04M(m)-$22.85M
2020-09-30$5.58M$7.00M$0.00-$6.92M
2019-09-30$4.77M$5.91M$0.00-$5.55M
2018-09-30$4.69M$5.98M$0.00-$5.66M
2017-09-30$3.58M$4.13M$0.00-$4.53M
2016-09-30$2.22M$2.42M$0.00-$2.41M

Revenue and expense 12 month

Period endResearch and developmentOperating expensesIncome taxNet income
2025-12-31$145.00M$172.19M(m)-$177.04M
2024-12-31$104.20M$113.27M(m)-$111.78M
2023-12-31$60.59M$66.23M(m)-$63.78M
2022-12-31$35.29M$39.39M(m)-$40.37M
2021-12-31$25.76M$28.36M(m)-$29.61M
2020-12-31$7.68M$9.56M$0.00-$9.47M
2019-12-31$6.27M$7.81M$0.00-$7.36M
2018-12-31$6.33M$7.93M$0.00-$7.48M
2017-12-31$4.98M$5.95M$0.00-$6.25M
2016-12-31$3.06M$3.33M$0.00-$3.31M

Similar stocks

Stock NameCountryMarket CapPE Ratio
VERACYTE, INC. (VCYT)United States$3.904B41.21
CareDx, Inc. (CDNA)United States$3.174B13.21
GRAIL, Inc. (GRAL)United States$5.591B-7.78
RadNet, Inc. (RDNT)United States$5.611B-229.65
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
BIODESIX INC (BDSX)United States$0.312B